1. Reunala T, Lokki J: Dermatitis herpetiformis in Finland. Acta Derm Venereol 58:505-510, 1978
2. Moi H: Incidence and prevalence of dermatitis herpetiformis in a country in central Sweden, with comments on the course of the disease and IgA deposits as diagnostic criterion. Acta Derm Venereol 64:144-150, 1984
3. Smith JB et al The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol 128:1608-1610, 1992
4. Paek SY, Steinberg SM, Katz SI: Remission in dermatitis herpetiformis: A cohort study. Arch Dermatol 2010 Nov 15. [Epub ahead of print]
5. Garioch JJ et al: 25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 131(4):541-545, 1994
6. Duhring LA. Dermatitis herpetiformis. JAMA 3:225, 1893
7. Marks J, Shuster S, Watson AJ: Small bowel changes in dermatitis herpetiformis. Lancet 1280-1282, 1966
8. Shuster S, Watson AJ, Marks J: Coeliac syndrome in dermatitis herpetiformis. Lancet 1101-1106, 1968
9. Fry L et al: Effect of gluten free-diet on dermatological, intestinal and haematological manifestations of dermatitis herpetiformis. Lancet 1:557-561, 1968
10. Weinstein WM: Latent celiac sprue. Gastroenterology 66:489-493, 1974
11. Reunala T et al: Tolerance to oats in dermatitis herpetiformis. Gut 43:490-493, 1998
12. Hardman CM et al: Absence of toxicity of oats in patients with dermatitis herpetiformis [see comments]. N Engl J Med 337:1884-1887, 1997
13. Savilahti E et al: Density of gamma/delta+ T cells in the jejunal epithelium of patients with coeliac disease and dermatitis herpetiformis is increased with age. Clin Exp Immunol 109:464-467, 1997
14. Smith AD et al: Expression of interleukin-4 and interferon-g in the small bowel of patients with dermatitis herpetiformis and isolated gluten-sensitive enteropathy. Dig Dis Sci 44:2124-2132, 1999
15. Hall RP, Smith AD, Streilein RD: Increased production of IL-4 by T cell lines from patients with dermatitis herpetiformis compared to patients with isolated gluten sensitive enteropathy. Dig Dis Sci 45:2036-2043, 2000
16. Hall RP3 et al: Cutaneous endothelial cell activation in normal skin of patients with dermatitis herpetiformis associated with increased serum levels of IL-8, sE-Selectin and TNF-a. J Invest Dermatol 126:1331-1337, 2006
17. Ward MM, Pisetsky DS, Hall RP. Soluble interleukin-2 receptor levels in patients with dermatitis herpetiformis. J Invest Dermatol 97:568-572, 1991
18. Smith AD, Streilein RD, Hall RP: Neutrophil CD11b, L-selectin and Fc IgA receptors in patients with dermatitis herpetiformis. Br J Dermatol 147:1109-1117, 2002
19. Samolitis NJ et al: Dermatitis herpetiformis and partial IgA deficiency. J Am Acad Dermatol 54:S206-S209, 2006
20. Dieterich W et al: Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 113:133-136, 1999
21. Sardy M et al: Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 195:747-757, 2002
22. Donaldson, M et al: Epidermal transglutaminase deposits in perilesional and uninvovled skin in patients with dermatitis herpetiformis. J Invest Dermatol 127(5):1268-1271, 2007
23. Dieterich W et al: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Medicine 3:797-801, 1997
24. Hull, CM et al: Elevation of IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis. Br J Dermatol 159(1):120-124, 2008
25. Preisz KF et al: Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol 19:74-79, 2005
26. Katz SI: Clinical and Histological overview. In: Katz, S.I. (moderator). Dermatitis herpetiformis: The skin and the gut. Ann Intern Med 1980;93:857-874.
27. Takeuchi F, Streilein RD, Hall RP: Increased E-selectin, IL-8 and IL-10 gene expression in human skin after minimal trauma: A potential explanation of regional distribution of skin lesions. Exp Dermatol 12:777-783, 2003
28. Airola K et al: Enhanced expression of interstitial
collagenase, stromelysin-1, and urokinase plasminogen activator in lesions of dermatitis herpetiformis.
J Invest Dermatol 105:184-189, 1995
29. Salmela MT et al: Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. Gut 48:496-502, 2001
30. Baker BS et al: Lack of proliferative response by gluten-specific T cells in the blood and gut of patients with dermatitis herpetiformis. J Autoimmun 8:561-574, 1995
31. Garioch JJ et al: T lymphocytes in lesional skin of patients with dermatitis herpetiformis. Br J Dermatol 131:822-826, 1994
32. Marietta E FAU - et al: A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest 114:1090-1097, 2004
33. Borghi-Scoazec G et al: Onset of dermatitis herpetiformis after treatment by interferon and
ribavirin for chronic hepatitis C.
J Hepatol 40:871-872, 2004
34. Yu SS et al: Dermatitis herpetiformis associated with administration of a gonadotropin-releasing hormone analog. J Am Acad Dermatol 54:S58-S59, 2006
35. van der Meer JB: Granular deposits of immunoglobulins in the skin of patients with dermatitis herpetiformis: An immunofluorescent study. Br J Dermatol 81:493-503, 1969
36. Cormane RH: Immunofluorescent studies of the skin in lupus erythematosus and other diseases. Pathologica Eur 2:170-187, 1967
37. Ko, CJ et al: Fibrillar IgA deposition in dermatitis herpetiformis–an underreported pattern with potential clinical significance. J CutanPathol 37:475-477, 2010
38. Seah PP et al: Immunoglobulins in the skin in dermatitis herpetiformis and coeliac disease. Lancet 1:611-614, 1972
39. Cannistraci C et al: Co-localization of IgA and TG3 on healthy skin of coeliac patients. J Eur Acad Dermatol Venereol 21:509-514, 2007
40. Seah PP, Fry L: Immunoglobulins in the skin in dermatitis herpetiformis and their irrelevance in the diagnosis. Br J Dermatol 92:157-166, 1975
41. Leonard J et.al: Gluten challenge in dermatitis herpetiformis. N Engl J Med 308:816-819, 1983
42. Reunala T: Gluten-free diet in dermatitis herpetiformis. II. Morphological and immunological findings in the skin and small intestine of 12 patients and matched controls. Br J Dermatol 98:69-78, 1978
43. Zone JJ, Meyer LJ, Petersen MJ: Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 132:912-918, 1996
44. Hall RP, Lawley TJ: Characterization of circulating and cutaneous IgA immune complexes in patients with dermatitis herpetiformis. J Immunol 135:1760-1765, 1985
45. Barghuthy FS et al: Identification of IgA subclasses in skin of dermatitis herpetiformis patients. Int Arch Allergy Appl Immunol 85:268-271, 1988
46. Hall RP, Waldbauer GV: Characterization of the mucosal immune response to dietary antigens in patients with dermatitis herpetiformis. J Invest Dermatol 1988 May 90:658-663, 1988
47. Hall RP, McKenzie KD: Comparison of the intestinal and serum antibody response in patients with dermatitis herpetiformis. Clin Immunol Immunopathol 62:t-41, 1992
48. Kantele, JM et al: Decreased numbers of circulating plasmablasts and differences in IgA-1 plasmablasts homing to skin in coeliac disease and dermatitis herpetiformis. Clin Exp Immunol 156:535-541, 2009
49. Katz SI et al: Effect of sulfones on complement deposition in dermatitis herpetiformis and on complement-mediated guinea-pig reactions. J Invest Dermatol 67:688-690, 1976
50. Ljunghall K, Tjernlund U: Dermatitis herpetiformis: Effect of gluten-restricted and gluten-free diet on
dapsone requirement and on IgA and C3 deposits in uninvolved skin.
Acta Derm Venereol 63:129-136, 1983
51. Dahlback K, Lofberg H, Dahlback B: Vitronectin colocalizes with Ig deposits and C9 neoantigen in discoid lupus erythematosus and dermatitis herpetiformis, but not in bullous pemphigoid. Br J Dermatol 120:725-733, 1989
52. Stingl G et al: Ultrastructural localization of immunoglobulins in skin of patients with dermatitis herpetiformis. J Invest Dermatol 67:507-512, 1976
53. Yaoita H. Identification of IgA binding structures in skin of patients with dermatitis herpetiformis. J Invest Dermatol 71:213-216, 1978
54. Karpati S et al: Dermatitis herpetiformis bodies. Ultrastructural study on the skin of patients using direct preembedding immunogold labeling. Arch Dermatol 126:1469-1474, 1990
55. Lightner
VA, Sakai LY, Hall RP: IgA-binding structures in dermatitis herpetiformis skin are independent of elastic-microfibrillar bundles.
J Invest Dermatol 1991 Jan 96:88-92, 1991
56. Dahlback K, Sakai L: IgA immunoreactive deposits collocal with fibrillin immunoreactive fibers in dermatitis herpetiformis skin. Acta Derm Venereol 70:194-198, 1990
57. Hallstrom O: Comparison of IgA-class reticulin and endomysium antibodies in coeliac disease and dermatitis herpetiformis [see comments]. Gut 30:1225-1232, 1989
58. Gaspari AA et al: Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 88:145-150, 1990
59. Zettinig et al: Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest 30:53-57, 2000
60. Hall RP et al: IgA-containing circulating immune complexes in dermatitis herpetiformis, Henoch-Schonlein purpura, systemic lupus erythematosus and other diseases. Clin Exp Immunol 40:431-437, 1980
61. Zone JJ, LaSalle BA, Provost TT: Circulating immune complexes of IgA type in dermatitis herpetiformis. J Invest Dermatol 1980 Aug 75:152-155, 1980
62. Chorzelski TP et al: IgA class endomysium antibodies in dermatitis herpetiformis and coeliac disease. Ann NY Acad Sci 420:325-334, 1983
63. Rose C et al: Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. J Am Acad Dermatol 61:39-43, 2009
64. Katz SI et al: HL-A8: A genetic link between dermatitis herpetiformis and gluten-sensitive enteropathy. J Clin Invest 51:2977, 1972
65. Katz SI et al: HLA-B8 and dermatitis herpetiformis in patients with IgA deposits in skin. Arch Dermatol 113:155-156, 1977
66. Reunala T et al: Histocompatibility antigens and dermatitis herpetiformis with special reference to jejunal abnormalities and acetylator phenotype. Br J Dermatol 94:139-143, 1976
67. Thomsen M et al: Association of LD-8a and LD-12a with dermatitis herpetiformis. Tissue Antigens 7:60-62, 1976
68. Keuning, JJ et al: HLA-DW3 associated with coeliac disease. Lancet 1:506-508, 1976
69. Park MS et al: The 90% incidence of HLA antigen (Te24) in dermatitis herpetiformis. Tissue Antigens 1983 Oct 22:263-266, 1983
70. Otley CC, Wenstrup RJ, Hall RP: DNA sequence analysis and restriction fragment length polymorphism (RFLP) typing of the HLA-DQw2 alleles associated with dermatitis herpetiformis. J Invest Dermatol 97:318-322, 1991
71. Hervonen K et al: Concordance of dermatitis herpetiformis and celiac disease in monozygous twins. J Invest Dermatol 115:990-993, 2000
72. Spurkland A et al: Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA- DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 49:29-34, 1997
73. Hervonen K et al: First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 37:51-55, 2002
74. Cianci R et al: Increased frequency of Ig heavy-chain HS1,2-A enhancer [ast]2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis. J Invest Dermatol 128:1920-1924, 2008
75. Pierard J, Whimster I: The histological diagnosis of dermatitis herpetiformis, bullous pemphigoid and erythema multiforme. Br J Dermatol 73:253, 1961
76. MacVicar, DN, Graham, JH, Burgoon, CF: Dermatitis herpetiformis, erythema multiforme and bullous pemphigoid: A comparative histopathological and histochemical study. J Invest Dermatol 41:289-300, 1963
77. Smith JB, Taylor TB, Zone JJ: The site of blister formation in dermatitis herpetiformis is within the lamina lucida. J Am Acad Dermatol 27:209-213, 1992
78. Klein GF et al: Junctional blisters in acquired bullous disorders of the dermal- epidermal junction zone: Role of the lamina lucida as the mechanical locus minoris resistentiae. Br J Dermatol 109:499-508, 1983
79. Stockbrugger R et al: Auto-immune atrophic gastritis in patient with dermatitis herpetiformis. Acta Derm Venereol 56:111-113, 1997
80. O'Donoghue DP et al: Gastric lesion in dermatitis herpetiformis. Gut 1976 Mar 17:185-188, 1976
81. Leonard JN et al: Increased incidence of malignancy in dermatitis herpetiformis. Br Med J 286:16-18, 1983
82. Collin P, Pukkala E, Reunala T: Malignancy and survival in dermatitis herpetiformis: A comparison with coeliac disease. Gut 38:528-530, 1996
83. Lewis HM et al: Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 135:363-367, 1996
84. Hervonen K et al: Lymphoma in patients with dermatitis herpetiformis and their first-degree relatives. Br J Dermatol 152:82-86, 2005
85. Viljamaa M et al: Malignancy and mortality in patients with coeliac disease and dermatitis herpetiformis: 30-year population based study. Digestive and Liver Disease 38:374-380, 2006
86. Lewis, NR et al: No increase in risk of fracture, malignancy or mortality in dermatitis herpetiformis: A cohort study. Aliment Pharmacol Ther 27(11):1140-1147, 2008
87. Fry L: Dermatitis herpetiformis. Baillieres Clin Gastroenterol 9:371-393, 1995
88. Reunala T, Collin P: Diseases associated with dermatitis herpetiformis. Br J Dermatol 136:315-318, 1997
89. Price, P et al: The genetic basis for the associationof the 8.1 ancestralhaplotype (A1,B8,DR3) with multiple immunopathological diseases. Immunol Rev 167:257-274, 1999
90. Bushara KO: Neurologic presentation of celiac disease. Gastroenterology 128:S92-S97, 2005
91. Helsing, P, Froen, H: Dermatitis herpetiformis presenting as ataxia in a child. Acta Derm Venereol 87:163-165, 2007
92. Wills AJ et al: Dermatitis herpetiformis and neurological dysfunction. J Neurol Neurosurg Psychiatry 72:259-261, 2002
93. Corazza GR et al: Bones in coeliac disease: Diagnosis and treatment. Best Pract Res Clin Gastroenterol 19:453-465, 2005
94. Di Stefano M et al: Bone mass and metabolism in dermatitis herpetiformis. Dig Dis Sci 44:2139-2143, 1999
95. Abuzakouk M et al: Dermatitis herpetiformis: No evidence of bone disease despite evidence of enteropathy. Dig Dis Sci 52:659-664, 2007
96. Griffiths CE, Leonard JN, Fry L: Dermatitis herpetiformis exacerbated by
indomethacin.
Br J Dermatol 112:443-445, 1985
97. Fry L et al: Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet 1:288-291, 1973
98. Kadunce DP et al: The effect of an elemental diet with and without gluten on disease activity in dermatitis herpetiformis. J Invest Dermatol 97:175-182, 1991
99. Zeedijk N et al: Dermatitis herpetiformis: Consequences of elemental diet. Acta Derm Venereol 66:316-320, 1986
100. Sladden MJ FAU, Johnston GA: Complete resolution of dermatitis herpetiformis with the Atkins' diet. Br J Dermatol 154:565-566, 2006